401 related articles for article (PubMed ID: 23062391)
1. Effect of oral immunotherapy to peanut on food-specific quality of life.
Factor JM; Mendelson L; Lee J; Nouman G; Lester MR
Ann Allergy Asthma Immunol; 2012 Nov; 109(5):348-352.e2. PubMed ID: 23062391
[TBL] [Abstract][Full Text] [Related]
2. Oral immunotherapy for the treatment of food allergy.
Ismail IH; Tang ML
Isr Med Assoc J; 2012 Jan; 14(1):63-9. PubMed ID: 22624447
[TBL] [Abstract][Full Text] [Related]
3. Successful oral tolerance induction in severe peanut allergy.
Clark AT; Islam S; King Y; Deighton J; Anagnostou K; Ewan PW
Allergy; 2009 Aug; 64(8):1218-20. PubMed ID: 19226304
[TBL] [Abstract][Full Text] [Related]
4. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
[TBL] [Abstract][Full Text] [Related]
5. Parental anxiety before and after food challenges in children with suspected peanut and hazelnut allergy.
Zijlstra WT; Flinterman AE; Soeters L; Knulst AC; Sinnema G; L'Hoir MP; Pasmans SG
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e439-45. PubMed ID: 19694978
[TBL] [Abstract][Full Text] [Related]
6. Clinical update on peanut allergy.
Sicherer SH
Ann Allergy Asthma Immunol; 2002 Apr; 88(4):350-61; quiz 361-2, 394. PubMed ID: 11991552
[TBL] [Abstract][Full Text] [Related]
7. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome.
Anagnostou K; Clark A; King Y; Islam S; Deighton J; Ewan P
Clin Exp Allergy; 2011 Sep; 41(9):1273-81. PubMed ID: 21414048
[TBL] [Abstract][Full Text] [Related]
9. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE.
Vander Leek TK; Liu AH; Stefanski K; Blacker B; Bock SA
J Pediatr; 2000 Dec; 137(6):749-55. PubMed ID: 11113829
[TBL] [Abstract][Full Text] [Related]
10. [Peanut anaphylaxis: the problem of hidden allergens].
Borelli S; Anliker MD; Wüthrich B
Dtsch Med Wochenschr; 1999 Oct; 124(41):1197-200. PubMed ID: 10572516
[TBL] [Abstract][Full Text] [Related]
11. Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.
Michaud E; Evrard B; Pereira B; Rochette E; Bernard L; Rouzaire PO; Gourdon-Dubois N; Merlin E; Fauquert JL
Trials; 2015 Apr; 16():197. PubMed ID: 25925398
[TBL] [Abstract][Full Text] [Related]
12. The natural history of persistent peanut allergy.
Neuman-Sunshine DL; Eckman JA; Keet CA; Matsui EC; Peng RD; Lenehan PJ; Wood RA
Ann Allergy Asthma Immunol; 2012 May; 108(5):326-331.e3. PubMed ID: 22541403
[TBL] [Abstract][Full Text] [Related]
13. Parental satisfaction with oral peanut food challenges; perception of outcomes and impact on management of peanut allergy.
Nguyen M; Wainstein BK; Hu W; Ziegler JB
Pediatr Allergy Immunol; 2010 Dec; 21(8):1119-26. PubMed ID: 20444148
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
[TBL] [Abstract][Full Text] [Related]
15. Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Fernandez-Rivas M; Vereda A; Vickery BP; Sharma V; Nilsson C; Muraro A; Hourihane JO; DunnGalvin A; du Toit G; Blumchen K; Beyer K; Smith A; Ryan R; Adelman DC; Jones SM
Allergy; 2022 Mar; 77(3):991-1003. PubMed ID: 34320250
[TBL] [Abstract][Full Text] [Related]
16. Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy.
Blackman AC; Staggers KA; Kronisch L; Davis CM; Anagnostou A
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):196-201.e1. PubMed ID: 32278075
[TBL] [Abstract][Full Text] [Related]
17. Peanut hypersensitivity in children.
Rancé F; Dutau G
Pediatr Pulmonol Suppl; 1999; 18():165-7. PubMed ID: 10093132
[TBL] [Abstract][Full Text] [Related]
18. Prevention of oral food allergy sensitization via skin application of food allergen in a mouse model.
Li W; Zhang Z; Saxon A; Zhang K
Allergy; 2012 May; 67(5):622-9. PubMed ID: 22339388
[TBL] [Abstract][Full Text] [Related]
19. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.
DunnGalvin A; Fleischer DM; Campbell DE; O'B Hourihane J; Green TD; Sampson HA; Greenhawt M
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):216-224.e1. PubMed ID: 32841748
[TBL] [Abstract][Full Text] [Related]
20. Peanut allergy: an overview.
Al-Muhsen S; Clarke AE; Kagan RS
CMAJ; 2003 May; 168(10):1279-85. PubMed ID: 12743075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
